A Wilmot Cancer Institute investigator discovered a gene that’s required for the initiation of melanoma and the growth of disseminated melanoma cancer cells in the lungs.
Jonathan Friedberg, a doctor at the Wilmot Cancer Center said the fact the president wants to make cancer research a national priority is exciting.
The School of Medicine and Dentistry houses the largest research resource of South African clawed frogs in the world, and researchers in Rochester and around the globe are using this frog model to better understand the minute details of how tumors grow and how the body reacts.
A University biomedical engineering lab has discovered a new way to judge whether breast cancer cells are likely to spread, by viewing tumor biopsies with a powerful multi-photon laser microscope and watching for certain optical patterns emitted by cancer.
Dr. Avice O’Connell, director of women’s imaging at the University of Rochester Medical Center in New York, said the new guidelines are more moderate and consider women under age 50 more seriously than those of the U.S. Preventive Task Force.
Through this network, Wilmot Cancer Institute and Roswell Park Cancer Institute in Buffalo — the state’s two largest cancer care and research institutions outside New York City — will collaborate and expand genomic testing for cancer across the Finger Lakes and western New York region.
It’s not often that Nature publishes on a new way of detecting cancer. Recently the journal reported that bits of cancerous cells – tiny blebs containing protein, RNA and DNA – can be measured in blood samples from patients with pancreatic cancer. These particles, exosomes, might serve as tumor indicators, or biomarkers.
Professor Danielle Benoit and her students will be serving lemonade and explaining their work on childhood cancer therapies this weekend as part of a national effort organized by Alex’s Lemonade Stand Foundation, which has helped fund her research.
New data from University scientists shows that cancer patients might feel their best if they simply maintain or only slightly increase their physical activity throughout chemotherapy instead of letting it decline.